Hsu Jason 4
4 · Immix Biopharma, Inc. · Filed Dec 20, 2021
Insider Transaction Report
Form 4
Hsu Jason
Director
Transactions
- Conversion
Common Stock
2021-12-20$0.85/sh+3,915,913$3,328,526→ 3,915,913 total(indirect: See Footnote) - Purchase
Common Stock
2021-12-20$5.00/sh+50,000$250,000→ 50,000 total(indirect: See Footnote) - Conversion
Convertible Note
2021-12-20→ 0 total(indirect: See Footnote)Exercise: $0.85→ Common stock (3,915,913 underlying)
Footnotes (3)
- [F1]Jason Hsu is the Sole Member of VERITAS LIBERABIT VOS, LLC ("VL") and in such capacity has the right to vote and dispose of the securities held by such entity.
- [F2]Jason Hsu is the Sole Member of Signature Collection Properties, LLC and in such capacity has the right to vote and dispose of the securities held by such entity.
- [F3]On September 1, 2016, the Registrant issued VL a note in the amount of $3 million which is payable upon request of the majority holders of like tenure notes on or after March 31, 2022. Pursuant to the terms of the note, because the Registrant sold equity securities in its initial public offering resulting in proceeds of at least $10 million, the note automatically converted into shares of the Registrant's common stock.